|
HS Code |
951303 |
| Product Name | (4-Boc-Aminophenyl)Boronic Acid |
| Cas Number | 856546-30-8 |
| Molecular Formula | C11H16BNO4 |
| Molecular Weight | 237.07 g/mol |
| Appearance | White to off-white solid |
| Melting Point | 210-215°C (decomposition) |
| Purity | Typically ≥98% |
| Solubility | Slightly soluble in water, soluble in DMSO, DMF, methanol |
| Storage Temperature | 2-8°C (refrigerated) |
| Smiles | CC(C)(C)OC(=O)Nc1ccc(B(O)O)cc1 |
| Inchi | InChI=1S/C11H16BNO4/c1-11(2,3)17-10(15)13-8-4-6-9(7-5-8)12(14)16/h4-7,14-16H,1-3H3,(H,13,15) |
| Synonyms | tert-Butyl 4-boronoaniline carbamate |
| Ec Number | None assigned |
As an accredited (4-Boc-Aminophenyl)Boronic Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The chemical is packaged in a sealed amber glass vial, labeled as 5 grams `(4-Boc-Aminophenyl)Boronic Acid`, with hazard information. |
| Shipping | (4-Boc-Aminophenyl)Boronic Acid is shipped in secure, airtight containers to prevent moisture and contamination. It is handled with care under temperature-controlled conditions, typically ambient or as specified by regulatory guidelines. Comprehensive documentation accompanies each shipment, ensuring safe transportation and compliance with all chemical shipping regulations. |
| Storage | (4-Boc-Aminophenyl)Boronic Acid should be stored in a cool, dry, and well-ventilated area, away from heat, moisture, and incompatible substances such as strong oxidizers and acids. Store in tightly sealed containers, protected from direct sunlight. Recommended temperature is 2-8°C (refrigerated). Ensure proper labeling and handle under an inert atmosphere if possible, as boronic acids are moisture-sensitive. |
Applications of (4-Boc-Aminophenyl)Boronic Acid in Industrial Manufacturing(4-Boc-Aminophenyl)Boronic Acid provides targeted utility across pharmaceutical, agrochemical, specialty polymer, and advanced material industries. As a dedicated raw material manufacturer, we collaborate with commercial partners on formulation and process optimization to meet strict compliance requirements and production targets in proprietary processes. Below we detail real downstream scenarios where this compound delivers measurable value. 1. Active Pharmaceutical Ingredient (API) Intermediate SynthesisThis compound is frequently used as a protected boronic acid in Suzuki–Miyaura cross-coupling reactions, enabling the construction of biphenyl and biaryl motifs in the synthesis of advanced API intermediates, particularly for oncology and autoimmune therapeutics. The Boc protecting group ensures stability throughout multi-stage synthesis lines and is efficiently removed under controlled deprotection conditions. Manufacturers require exacting consistency and traceability in every batch for successful validation and regulatory submission. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Targeted Fluorophore and Diagnostic Reagent ProductionWithin life science instrumentation and clinical assay development, this boronic acid enables regioselective attachment of amino-functionalized building blocks onto fluorescent scaffolds. It supports synthesis of specialized probes for flow cytometry, immunoassays, and cell imaging. Protection with Boc group prevents self-condensation during early coupling, securing high product purity. End users require strict batch-to-batch reproducibility and full analytical trace profiles. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Advanced Agrochemical FormulationThis raw material plays a critical role in the synthesis of next-generation aryl boron–containing agrochemical actives, including selective herbicides and fungicide intermediates. Integration of the protected amine functionality enhances selectivity and downstream derivatization of the core structure. Process reliability and environmental safety data are essential during manufacture and subsequent regulatory registration. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Specialty Polymer and Advanced Material SynthesisIndustrial polymer R&D teams use this compound to prepare functionalized aromatic monomers for high-performance copolymers and surface-active materials. The amine-protecting group ensures compatibility with free-radical or step-growth polymerization conditions. Incorporation enhances material binding, optical, or electronic properties, supporting film, membrane, and coating applications. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Chemical Research and Combinatorial Library PlatformsIn high-throughput synthesis labs and discovery chemistries, this compound is broadly adopted as a building block for solid-phase or parallel library construction. The dual functionality accelerates rapid assembly of arylated amine libraries for pharmaceutical and petrochemical innovation. Consistent particle morphology and solubility facilitate automation and purity control during downstream processing. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive (4-Boc-Aminophenyl)Boronic Acid prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
As a chemical manufacturer specializing in advanced boronic acids, we've seen the subtle impact that the right functional groups can make on synthetic pathways. (4-Boc-Aminophenyl)Boronic Acid stands out in our catalog for that reason. This compound, with CAS No. 1073356-79-8 and the typical molecular formula C11H16BNO4, features a Boc-protected amine in the para position of a phenylboronic core—a structure that chemists have learned to appreciate in many cross-coupling reactions and medicinal chemistry explorations.
In real laboratory practice, protecting groups often make or break a synthesis. The Boc group in (4-Boc-Aminophenyl)Boronic Acid provides temporary shielding for the amino group, helping researchers avoid unwanted side reactions during complex Suzuki-Miyaura couplings or Chan-Lam reactions. Over the years, we have scaled up the production of this compound, paying attention to purity—typically reaching levels above 98% by HPLC. Chemists find the removable Boc group invaluable, since it can be cleaved under mild acidic conditions, revealing the free amine for downstream modifications.
In our experience, (4-Boc-Aminophenyl)Boronic Acid often moves directly into the toolkits of discovery chemists. The utility shows up in the construction of biaryl scaffolds, heterocycles, and even in the design of small-molecule inhibitors targeting kinases. Pharmaceutical partners have reached for this compound when developing lead structures that eventually advance into clinical trials. The compound’s robust shelf life, when stored away from moisture and light, means it can usually stay stable and effective throughout multi-step workflows. Unlike some other boronic acids, we notice that this derivative handles repeated days at ambient temperature without decomposing or polymerizing—attributes that matter to chemists running parallel syntheses or compiling screening libraries.
A chemist’s choice between (4-Boc-Aminophenyl)Boronic Acid and other boronic acids depends on several factors, including downstream transformations, overall molecule design, and compatibility with catalytic cycles. Our production labs have seen requests for a range of boronic acids, from simple phenylboronic acid to highly substituted, electronically complex variants. The Boc-protected para-amino group gives this acid its unique niche. Compared with its close cousin, 4-aminophenylboronic acid (without the Boc), our product offers better protection against base-sensitive transformations. In peptide conjugations or multi-component reactions, the stable, removable Boc group can spell the difference between a clean final product and a mixture complicated by side products or polymerization.
Our workshops have dialed in the specifications that matter most: crystalline white-to-off-white solid, melting in the approximate range of 183°C to 187°C, high chemical purity, and reliable batch reproducibility. The substance dissolves in solvents such as dimethyl sulfoxide and dimethylformamide, giving medicinal chemists flexibility for various coupling setups. During years of scale-up experience, we’ve paid close attention to particle size to improve handling and dosing, minimizing dust at the bench and supporting precise weighing—even for automated liquid handling systems. Every batch leaves our facility accompanied by full HPLC and NMR data, supporting structure confirmation and impurity checks.
In pre-clinical workflows, requests have come in for both gram and multi-kilogram volumes, meaning scale is never out of reach. Each time we produce a lot, we pay attention to trace water content since even a little moisture can undermine downstream Suzuki couplings. To support teams who need lots for high-throughput screening, we invest in drying and robust packaging—avoiding glass-to-glass static and caking that can frustrate rapid transfer on automated platforms.
Unlike distributors who pass sealed jars downstream, we forge direct partnerships with process development scientists. Over the years, we’ve learned that transparency and traceability are non-negotiable. No one wants a failed run because of variable boronic acid sources. Product consistency, ensured through lot tracking and periodic stability testing, remains central to our deliveries. The knowledge gained from actual feedback has led us to refine our purification steps, monitor for trace metals, and aim for sub-0.5% water content—crucial numbers for both scale-up and bench chemistry.
Beyond analytical results, logistics and inventory make a difference. On several occasions, project timelines tightened after a customer realized their stock had expired or picked up moisture. We have responded with flexible delivery schedules and just-in-time batch production, knowing that real-time needs in pharma and agrochem can shift quickly. The result: supply is both reliable and responsive, so teams don’t have to interrupt workflows hunting for a rare intermediate.
Modern chemical production does not only revolve around purity and yield—safety and environmental compliance matter just as much. Years back, batch processes for boronic acid derivatives leaned on stoichiometric quantities of organometallic reagents with waste streams that needed careful remediation. Our plant has shifted toward using greener routes, with in-line monitoring to limit side reactions and lower solvent waste. This isn’t just about meeting government regulations—it reduces the chemical footprint for everyone down the research pipeline.
We have also faced the challenge of trace environmental contaminants, especially with boron-containing intermediates. Our labs screen final product lots for residual solvents and heavy metals, driven both by regulatory expectations and feedback from downstream partners preparing APIs. Each improvement in waste reduction or in the control of metal catalysis trickles down to the research bench, where confidence in starting materials reduces surprises in the data.
Our relationships with synthesis teams drive us to refine the details others miss—whether it’s improving packaging integrity to reduce static or offering technical support that actually reflects years of hands-on production. Discussions with researchers over the years highlight consistent challenges: water sensitivity, packaging for high-throughput automation, and removing the Boc group without compromising yield. We’ve shared dozens of technical bulletins with end users, supporting creative solutions: optimizing deprotection conditions, minimizing exposure to base, and guiding teams on choosing solvents that minimize byproducts during coupling.
Because we’re the ones actually making (4-Boc-Aminophenyl)Boronic Acid, we take customer feedback seriously. That sometimes means iterating on purification steps to cut difficult byproducts, or developing packaging that keeps powder flowing even after months in storage. Our knowledge doesn’t come from resale data or industry white papers—but straight from solving problems on the floor, testing batches, and working alongside synthetic chemists.
Every compound must earn its place in a researcher’s workflow. (4-Boc-Aminophenyl)Boronic Acid has endured cycles of changing chemistry trends because of a few key characteristics. The para Boc-protected amine gives researchers the ability to assemble complex fragments, mask reactive sites, and unmask them only as the synthesis demands. This flexibility fosters creativity in drug discovery and advanced material synthesis. Over the years, we have noticed a recurring theme: teams return for this compound not just for standard cross-coupling, but for unique, elaborate constructs—often in cutting-edge medicinal chemistry programs.
Compared to simpler boronic acids, which offer only basic arylation capacity, our Boc-protected version lets synthetic teams imagine beyond standard frameworks. We’ve seen it serve as a lynchpin for installing functional handles, enabling molecules that reach further into chemical space—hard to achieve with run-of-the-mill phenylboronic acids. In constructing libraries where amine reactivity plays a central role, the Boc group controls timing and order, reducing step counts and purifications. Over multiple projects, project leads have remarked on the distinctly clean profiles and yield bumps traced directly to controlled Boc removal.
The ideal boronic acid doesn’t just deliver reactivity; it also needs to survive the real conditions of the lab. (4-Boc-Aminophenyl)Boronic Acid copes well with shelf storage thanks to steady crystallinity and low volatility. Still, water presents a universal challenge. Our technical team often advises labs to keep containers tightly sealed and to aliquot powder into smaller vials, especially for larger volumes, to avoid exposure during long projects. Chemists working on automation platforms value the free-flowing nature that results from our attention to bulk density and particle treatment—details impossible to appreciate without handling the material regularly.
Any boronic acid presents the risk of slow hydrolysis if handled without regard for humidity. We tackle these issues by using moisture-barrier liners and nitrogen-purged containers, so even teams working in high-humidity regions experience less degradation before use. Our approach takes into account feedback on dosing accuracy for solid-phase and solution-phase synthesis, working toward a standard that supports both screening and scale-up.
Over the years, as requests for quantities have increased, particularly for parallel library synthesis, we’ve shifted our supply model to focus on batch-to-batch harmony. After many conversations with QC managers and synthesis leaders, we’ve improved documentation, offering real-time batch analytics accessible up to lot expiry. When technical hurdles arise—such as unexpected insolubility or lower yield on deprotection—our support goes straight to root-cause analysis, drawing from process data without the lag of distributor communication channels.
We maintain open lines with several development teams, troubleshooting and offering process tweaks informed by real-world production runs. Because we remain intimately connected to each lot, our technical advice tracks back to how the material actually behaves under thermocycling, high agitation, or dilute concentrations—concerns that often escape notice in abstract technical papers.
Over the last decade, evolving synthetic methodologies and the emergence of high-throughput screening have changed what chemists expect from every intermediate. (4-Boc-Aminophenyl)Boronic Acid has kept pace because it does more than just link aryl groups; it adds flexibility, enabling innovations in pharmaceutical design and material science. Laboratories working on fragment-based screening appreciate the compatibility with modern coupling protocols, including palladium and copper catalysis, which require stable, high-purity building blocks.
We have watched as growing demand for bioorthogonal handles and advanced conjugation techniques heightens expectations for amine protection and controlled release. Research teams working on small-molecule probes, functionalized polymers, and API intermediates value the options Boc protection unlocks. We actively monitor shifting environmental standards, reformulating our own process to reduce hazardous waste and align with greener chemistry goals. Working directly with our team, partners find that product improvements flow from real problem-solving on the production floor—not just regulatory compliance.
From bench-scale synthesis to industrial supply, producing (4-Boc-Aminophenyl)Boronic Acid has shown us every nuance of boronic acid chemistry. The product’s performance under varied user conditions means we’re always testing, always seeking refinements in crystallization, drying, and packaging. It’s not enough to reach a purity threshold; ongoing real-world use reveals quality gaps that internal laboratories catch before major problems occur down the line. By handling every part of the workflow ourselves, the chain of accountability stays unbroken.
The demands from our partners keep us sharp. Each project, whether a 25-gram pilot or an eighty-kilogram campaign, puts our quality approach to the test. We take pride in the direct feedback loop—if a run stalls because of handling issues, we work through it, adjusting processes to limit risk next time. Years of hands-on experience mean our solution doesn’t come from abstract process diagrams but steady refinements, observation, and adaptability.
In the competitive world of pharmaceutical research and synthetic chemistry, small shifts in intermediate choice can lead to breakthrough discoveries—or bottlenecks that delay a program. (4-Boc-Aminophenyl)Boronic Acid keeps its role in synthetic routes because it combines robust protection, predictable reactivity, reliable physical properties, and a level of purity that stands up to clinical demands. Every improvement we achieve with this compound gets tested, refined, and verified through collaborative projects with innovation-focused chemists.
The daily work of manufacturing isn’t glamorous, but it brings us close to the needs and frustrations of the research teams we serve. Every packed jar, every spec met, and every logistics problem solved adds a layer of trust that no third-party repackager can replicate. We know that chemists don’t just want a bottle—they want partnership, feedback, and shared problem-solving. That’s what we build into every batch of (4-Boc-Aminophenyl)Boronic Acid, so their discoveries can keep moving forward, one reaction at a time.